Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects

Vaccine

Volumn 30, Issue 32, 2012, Pages 4785-4789

  Liu, Wei ^a   Ma, Mai Juan ^a   Tang, Fang ^b   He, Cui ^a   Zhang, Xiao Ai ^a   Jiang, Lan Fen ^c   Xin, Dong Sheng ^c   Hu, Chun Yan ^a   Looman, Caspar ^d   Cao, Wu Chun ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Center for Diseases Control and Prevention of Chinese Peoples' Armed Police Forces   (China)

^c Center for Diseases Control and Prevention in ZhaLaiNuoEr District   (China)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cohort; Influenza; Serology; Vaccine

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FOLLOW UP; HALF LIFE TIME; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SEASONAL INFLUENZA; SINGLE DRUG DOSE; SKIN BRUISING; SKIN REDNESS; TREATMENT RESPONSE; VACCINATION REACTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CHINA; CROSS PROTECTION; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862523230     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.030     Document Type: Article

References (15)

1. New influenza A/H1N1 virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009, 84:249-257.
2. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009, 361:2414-2423.
3. Plennevaux E., Sheldon E., Blatter M., Reeves-Hoché M.K., Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010, 375:41-48.
4. Wu J., Li W., Wang H.Q., Chen J.T., Lv M., Zhou J.C., et al. A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial. J Infect Dis 2010, 202:675-680.
5. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361:2405-2413.
6. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine-preliminary report. N Engl J Med 2009, 361:2424-2435.
7. World Health Organization. CDC protocol of realtime RT PCR for swine influenza A (H1N1). [accessed 7.03.10]. http://www.who.int/csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_20090428.pdf.
8. World Health Organization Serologic diagnosis of influenza virus infections by hemagglutination inhibition. WHO manual on animal influenza diagnosis and surveillance 2002, World Health Organization, Geneva, [accessed 1.05.10]. http://www.who.int/csr/resources/publications/influenza/en/whocdscsrncs20025rev.pdf.
9. Crotty S., Aubert R.D., Glidewell J., Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004, 286:111-122.
10. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915.
11. Liu W., de Vlas S.J., Tang F., Ma M.J., Wei M.T., Liu L.J., et al. Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination. Clin Infect Dis 2010, 51:1028-1032.
12. Vajo Z., Tamas F., Sinka L., Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010, 375:49-55.
13. Wu J., Zhong X., Li C.K., Zhou J.F., Lu M., Huang K.Y., et al. Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 2011, 29:1009-1016.
14. Ellebedy A.H., Ducatez M.F., Duan S., Stigger-Rosser E., Rubrum A.M., Govorkova E.A., et al. Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets. Vaccine 2011, 29:3335-3339.
15. Garcia-Garcia L., Valdespino-Gómez J.L., Lazcano-Ponce E., Jimenez-Corona A., Higuera-Iglesias A., Cruz-Hervert P., et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. Br Med J 2009, 339:b3928.